Six Months Sufficient For CMS In-House NCDs – HHS Reg Reform Panel
This article was originally published in The Gray Sheet
Executive Summary
CMS should impose a six-month timeframe for all in-house national coverage determinations (NCDs) for new technology items, the HHS Secretary's Advisory Committee on Regulatory Reform final report recommends
You may also be interested in...
CMS Med-Tech Council Will Shorten Coverage Decision Process, Agency Says
The feasibility of opening the Medicare benefit category determination process to public scrutiny will be explored by CMS' Medical Technology Council at its inaugural meeting in early April
CMS Med-Tech Council Will Shorten Coverage Decision Process, Agency Says
The feasibility of opening the Medicare benefit category determination process to public scrutiny will be explored by CMS' Medical Technology Council at its inaugural meeting in early April
FDA Will Play Supporting Role, Not Preside Over Cost-Effectiveness Criteria
The growing call for greater federal cost-effectiveness evaluation of new medical technologies will not alter FDA's primary focus on risk-benefit analysis